Lymphomas
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin�s Lymphoma (UTX-TGR-205)
- Details
ClinicalTrials.gov ID:
NCT02793583
Diagnosis Type:
Non-Hodgkins
USOR Number:
- Address
5206 Research Dr
San
Antonio, TX 75204
P: (210) 595-5300